# FibroGen, Inc. (KYNB) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$45M |
| 2024 | -$131M |
| 2023 | -$269M |
| 2022 | -$301M |
| 2021 | -$289M |
| 2020 | -$192M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$14M |
| 2025-12-31 | -$14M |
| 2025-09-30 | -$5M |
| 2025-06-30 | -$12M |
| 2025-03-31 | -$15M |
| 2024-12-31 | -$91M |

Source: [CompaniesByCap](https://companiesbycap.com/company/KYNB/operating-income)